The company has been included in the first U.S. psychedelics-focused ETF.
Compare SEEL Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
Seelos Therapeutics Inc
News & Analysis: Seelos Therapeutics Inc
Good news from a clinical study was overshadowed by a recommendation downgrade from an analyst.
An analyst is really bullish about the biotech stock.